11/12/2025 16:05
UBS lowered the target price for Giant Biogene (02367) to HKD39.5 from HKD79.5 and downgraded the rating to "neutral" from "buy".
The research house said it is turning more cautious about the near-term sales growth outlook and expects Giant Biogene's sales growth to decelerate to 5% during 2026-28.
【你點睇？】宏福苑五級火過後，地產商會正研究地盤全面禁煙，你認為是否可行？► 立即投票
上一篇新聞︰12/12/2025 14:40 {I-bank focus}Morgan raises COSCO Ship Hold to HKD10.3
下一篇新聞︰11/12/2025 14:32 {I-bank focus}J.P. Morgan lowers Brilliance Chi to HKD4.1
12/12/2025 16:08 {I-bank focus}Citi lowers China Res Power (00836) to HKD19
09/12/2025 16:02 {I-bank focus}Citi lowers HKEX (00388) to HKD505
09/12/2025 15:10 {I-bank focus}Citi raises Brilliance Chi (01114) to HKD4.8
08/12/2025 16:04 {I-bank focus}HSBC lowers Giant Biogene (02367) to HKD46.4
